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Abstract: Surface-associated marine bacteria are an interesting source of new secondary 
metabolites. The aim of this study was the isolation and identification of epiphytic bacteria 
from the marine brown alga, Bifurcaria bifurcata, and the evaluation of the antioxidant and 
antimicrobial activity of bacteria extracts. The identification of epiphytic bacteria was 
determined by 16S rRNA gene sequencing. Bacteria extracts were obtained with methanol 
and dichloromethane (1:1) extraction. The antioxidant activity of extracts was performed 
by quantification of total phenolic content (TPC), 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
radical scavenging activity and oxygen radical absorbance capacity (ORAC). Antimicrobial 
activities were evaluated against Escherichia coli, Pseudomonas aeruginosa, Bacillus 
subtilis, Salmonella enteritidis, Staphylococcus aureus, Saccharomyces cerevisiae and 
Candida albicans. A total of 39 Bifurcaria bifurcata-associated bacteria were isolated and 
33 were identified as Vibrio sp. (48.72%), Alteromonas sp. (12.82%), Shewanella sp. 
(12.26%), Serratia sp. (2.56%), Citricoccus sp. (2.56%), Cellulophaga sp. (2.56%), 
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Ruegeria sp. (2.56%) and Staphylococcus sp. (2.56%). Six (15.38%) of the 39 bacteria 
Bifurcaria bifurcata-associated bacteria presented less than a 90% Basic Local Alignment 
Search Tool (BLAST) match, and some of those could be new. The highest antioxidant 
activity and antimicrobial activity (against B. subtilis) was exhibited by strain 16 
(Shewanella sp.). Several strains also presented high antimicrobial activity against  
S. aureus, mainly belonging to Alteromonas sp. and Vibrio sp. There were no positive 
results against fungi and Gram-negative bacteria. Bifurcaria bifurcata epiphytic bacteria 
were revealed to be excellent sources of natural antioxidant and antimicrobial compounds. 
Keywords: marine microorganisms; natural compounds; human pathogenic; Alteromonas sp.; 
Shewanella sp.; antibacterial; surface-associated microorganisms; marine symbiosis; 
macro-algae; seaweeds 
 
1. Introduction 
The marine environment is extremely complex and contains a huge diversity of life forms, which is 
a huge source of biological and chemical diversity [1–3]. The complex interactions between biological 
and chemical factors stimulate marine organisms to produce a high spectrum of different compounds 
with biological activities [4,5]. Among other reasons, marine organisms produce these compounds as a 
response to ecological pressures, since they survive and live within complex communities and in close 
association with other organisms in a very exigent, competitive and aggressive surrounding [4,6]. 
Sharing a common environment over a long evolutionary period also allowed the establishment of 
well-balanced associations between many of these organisms [7]. The surfaces of marine eukaryotes 
provide a unique habitat for microorganisms colonization, where competition between members of 
these communities and chemically-mediated interactions with their host are thought to influence both 
microbial diversity and function [8]. This close association of marine eukaryotes with microorganisms 
improves their physiological capacities, mainly providing microbial defenses [9]. For sessile marine 
organisms, like macro-algae, this association is an important strategy of survival in the environment 
where they live, since it is known that marine microorganisms strengthen the host defense mechanism 
by producing various kinds of secondary metabolites. Many of these metabolites have been recognized 
to be rich in chemical and biological properties [10,11]. Studies focusing on symbiotic relationships in 
marine environment indicate that many bioactive compounds previously found in marine animals and 
plants were in fact produced or metabolized by associated microorganisms [12–14]. For these reasons, 
in recent years, microorganisms associated with the surfaces of marine eukaryotes have been major 
targets for the discovery of new bioactive metabolites [15]. 
Among marine organisms, macro-algae can host varieties of heterotrophic bacteria, and many of 
these bacteria play an important role in maintaining the health of the host organism by producing 
unique bioactive secondary metabolites. With the increasing need for novel drug discovery, an 
understanding of the marine epiphyte-host associations outlined above is likely to deliver a rich source 
of preexisting and of new high value-added biomolecules with the potential for providing sustainable 
economic and human benefits [8,9,16,17]. These bioactive compounds with biomedical potential can 
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have an important role in the prevention or treatment of human diseases, like infectious diseases and 
diseases associated with oxidative damage that have a high impact in world society. 
Bifurcaria bifurcata is a perennial brown alga, found abundantly along the North East Atlantic 
shores, from Ireland as the northern limit, to south of the Western Sahara as the southern limit [18]. 
Previous studies reported a high antioxidant and antimicrobial potential in Bifurcaria bifurcata  
extracts [19,20]. However, little is known about the biodiversity of its associated bacteria and their 
capacity in the production of bioactive compounds. Therefore, the aim of this study was the isolation 
and identification of epiphytic bacteria from Bifurcaria bifurcata and the evaluation of the antioxidant 
and antimicrobial activities of extracts obtained from the isolated strains. 
2. Results and Discussion 
The oceans are massively complex and consist of diverse assemblages of life forms. The water 
column of the oceans contains approximately 10
6
 bacterial cells per milliliter [21]. In this study, 39 
phenotypic different bacteria from the Bifurcaria bifurcata surface were isolated, and the strains were 
subjected to molecular identification using 16S rRNA gene sequencing. 
As shown in Table 1, Vibrio sp. was the most common bacteria, representing 48.72% of all the  
B. bifurcata isolated bacteria. Bacteria belonging to the Vibrionaceae family are widespread in the 
marine environment. This family is particularly abundant on the surface of marine macroorganisms, 
where they form commensal, symbiotic or pathogenic associations [22]. Alteromonas sp. and 
Shewanella sp. were the following more representative genus, with 12.82% and 12.26% of occurrence, 
respectively. Both strains are frequent in the marine environment and have already been found to be 
associated with marine invertebrates, namely sponges and algae [23,24]. Cellulophaga sp.,  
Serratia sp., Ruegeria sp., Staphylococcus sp. and Citricoccus sp. were represented by one strain each 
(2.56%). However, these bacteria are found to be frequently associated with marine invertebrates and 
have been the focus of study by other authors [11,25–28]. 
Table 1. The identification of epiphytic bacteria isolated from Bifurcaria bifurcata, at the 
genus level. BLAST, Basic Local Alignment Search Tool. 
Epiphytic Bacteria Genus Occurrence (%) 
1 Citricoccus sp. 2.56 
2; 3; 10; 11; 13; 14; 15; 18; 20; 21; 
22; 23; 29; 31; 35; 39; 40; 50; 51 
Vibrio sp. 48.72 
4 Cellulophaga sp. 2.56 
6; 12; 28; 30; 34 Alteromonas sp. 12.82 
13B Serratia sp. 2.56 
16; 17; 25; 26 Shewanella sp. 12.26 
27 Ruegeria sp. 2.56 
32 Staphylococcus sp. 2.56 
8; 9; 24; 36; 38; 44 <90% BLAST match 15.38 
Marine bacteria develop unique metabolic and physiological capabilities, which enable them to 
survive in extreme habitats and to produce compounds that might not be produced by their  
terrestrial counterparts [1,6]. 
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In this work, marine bacteria were isolated from the brown alga, Bifurcaria bifurcata, and screened 
for their antioxidant and antimicrobial capacities. Since there is not a specific method to evaluate the 
antioxidant activity of a compound/extract, due to different antioxidant mechanisms, the antioxidant 
activity was evaluated through three methods, namely, oxygen radical absorbance capacity (ORAC), 
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and total phenolic content (TPC). 
The antioxidant results are stated in Table 2. The TPC was evaluated by the Folin-Ciocalteu 
method, and the results are expressed as gallic acid equivalents per gram of extract (GAE/g extract). 
Bacteria 16, belonging to the Shewanella genus, showed the highest phenolic content  
(53.854 ± 3.02 GAE/g extract) followed by Bacteria 8 (14.222 ± 4.25 GAE/g extract) and 36  
(10.376 ± 1.58 GAE/g extract). There are not many works quantifying the total phenolic content of 
marine bacteria, especially epiphytic algae. However, a total phenolic content of 0.22 mg GAE/g of 
extract was found on the marine Actinobacteria, which was significantly lower when compared with 
the results obtained by the B. bifurcata-associated bacteria study [29]. Moreover, the phenolic content 
found on Bacteria 16 was surprisingly high, even when compared with the total phenolic content of 
some macro-algae [30]. 
Table 2. Antioxidant activity of Bifurcaria bifurcata epiphytic bacteria. The results are the 
mean ± SEM of four independent experiments. TPC, total phenolic content; GAE, gallic 
acid equivalents; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ORAC, oxygen radical absorbance 
capacity; TE, trolox equivalents; BHT, butylated hydroxytoluene. 
Epiphytic 
Bacteria 
TPC  
(mg GAE/g Extract) 
DPPH Radical Scavenging 
Activity IC50 (µg/mL) 
ORAC  
(µmol TE/g Extract) 
1 3.040 ± 0.32 >1000 417.245 ± 9.44 
2 7.120 ± 0.05 >1000 43.220 ± 6.41 
3 2.080 ± 0.19 >1000 254.218 ± 6.47 
4 1.352 ± 0.09 >1000 154.985 ± 3.04 
6 2.923 ± 0.05 >1000 242.595 ± 6.68 
8 14.222 ± 4.25 164.40 (109.40–247.10) 912.621 ± 23.79 
9 4.870 ± 0.02 >1000 34.420 ± 1.63 
10 6.090 ± 0.07 >1000 20.400 ± 4.99 
11 6.530 ± 0.05 183.80 (118.50–285.20) 31.220 ± 2.06 
12 2.540 ± 0.30 >1000 215.289 ± 7.46 
13 9.750 ± 0.04 >1000 33.950 ± 4.40 
14 5.990 ± 0.06 >1000 47.950 ± 5.77 
15 5.390 ± 0.07 >1000 29.370 ± 2.62 
16 53.854 ± 3.02 20.21 (14.41–28.34) 3603.659 ± 53.38 
17 6.470 ± 0.09 >1000 44.250 ± 2.28 
18 1.633 ± 0.19 >1000 202.810 ± 4.75 
20 7.140 ± 0.01 >1000 52.110 ± 8.20 
21 1.668 ± 0.06 >1000 131.556 ± 2.36 
22 0.878 ± 0.06 >1000 119.415 ± 3.05 
23 2.035 ± 0.15 >1000 561.990 ± 12.69 
24 3.220 ± 0.25 >1000 407.490 ± 5.39 
25 9.380 ± 0.06 >1000 42.720 ± 4.08 
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Table 2. Cont. 
26 5.656 ± 0.13 521.00 (366.90–739.70) 520.917 ± 14.13 
27 2.640 ± 0.01 >1000 12.210 ± 0.68 
28 1.848 ± 0.21 >1000 149.545 ± 5.53 
29 1.117 ± 0.13 >1000 67.211 ± 0.99 
30 3.502 ± 0.12 >1000 68.979 ± 0.93 
31 8.556 ± 1.89 >1000 692.260 ± 13.61 
32 1.963 ± 0.21 >1000 201.190 ± 4.99 
34 2.220 ± 0.16 >1000 204.646 ± 1.89 
35 2.770 ± 0.04 >1000 358.226 ± 14.32 
36 10.376 ± 1.58 587.70 (442.00–781.40) 129.665 ± 0.91 
38 5.340 ± 0.07 >1,000 55.290 ± 3.11 
39 7.150 ± 0.03 23.62 (19.45–28.68) 36.100 ± 4.69 
40 5.900 ± 0.02 >1000 71.000 ± 15.49 
44 3.772 ± 0.44 >1000 97.450 ± 2.11 
50 4.106 ± 0.02 >1000 33.120 ± 0.42 
51 1.586 ± 0.89 >1000 246.910 ± 9.97 
13B 4.270 ± 0.02 >1000 18.880 ± 0.24 
BHT - 40.55 (27.39–60.05) - 
Regarding the DPPH radical scavenging activity, the highest potency was produced by Bacteria 16 
(Shewanella sp.) and Bacteria 39 (Vibrio sp.), which showed an IC50 of 20.21 (14.41–28.34) µg/mL 
and 23.6 (19.5–28.7) µg/mL, respectively. The Bacteria 8, 11, 26 and 36 also denoted quite  
high antioxidant activity on the reduction of DPPH with an IC50 of 164 (109–247) µg/mL, 183.8 
(118.5–285.2) µg/mL, 521 (366.9–739.7) µg/mL and 587.7 (442–781.4) µg/mL, respectively. These 
results are extremely interesting, especially when compared with the synthetic antioxidant, BHT 
(butylated hydroxytoluene), which presented an IC50 of 40.55 (27.39–60.05) µg/mL, since Bacteria 16 
and 39 presented more potency in scavenging the DPPH radical. Kalirajan and co-workers [31] 
evaluated the DPPH radical scavenging activity of bacteria associated with a marine sponge and 
obtained an IC50 of 857.49 µg/mL, which is 40 times less potent than that obtained for Bacteria 16 and 
39 in our work. 
Recently, the ORAC assay has received much attention as a new in vitro method for measuring the 
antioxidant activity of marine extracts by evaluating their ability to scavenge certain peroxyl-radicals 
that induce oxidation in the presence of fluorescein [32]. According to Zulueta and co-workers [33], 
the ORAC method is the only one so far that combines the total inhibition time and the percentage of 
the free-radical damage by the antioxidant into a single quantity, ensuring that, by the end of the 
process, all the antioxidants present in the sample have reacted with the radicals generated. Further 
evaluation of the peroxyl scavenging activity of the B. bifurcata epiphytic bacteria extracts was also 
conducted by ORAC assay, and the results were expressed as trolox equivalents per gram of extract  
(TE/g extract). Once more, Bacteria 16 showed the highest antioxidant activity with an ORAC value of 
3603.659 ± 53.38 µmol of TE/g extract, followed by Bacteria 8, 31, 23 and 26 with 912.621 ± 23.79 µmol 
of TE/g extract, 692.260 ± 13.61 µmol of TE/g extract, 561.990 ± 12.69 µmol of TE/g extract and 
520.917 ± 14.13 µmol of TE/g extract, respectively. The lack of information about the production of 
antioxidant compounds produced by marine epiphytic bacteria, namely evaluated by the ORAC 
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method, does not allow us to make a direct comparison with other works; however, Wang and  
co-workers [34] evaluated the peroxyl radical scavenging activity also by the ORAC system in  
10 macro-algae species from Iceland, and they obtained values ranging from 4 to 2567 µmol of TE/g 
extract, which are values substantially lower than the results obtained by our bacteria extracts, since 
the lowest result was 12.210 ± 0.68 µmol of TE/g of extract (Bacteria 27) and the highest was 
3603.659 ± 53.38 µmol of TE/g of extract (Bacteria 16). 
The high antioxidant activity of B. bifurcata epiphytic bacteria presented in this work can be 
explained by the environmental conditions where these bacteria exist. They live in close association 
with soft-bodied marine organisms, which lack obvious structural defense mechanisms, and, thus, rely 
on chemical defense by the production of bioactive secondary metabolites to survive in their extreme 
habitat [1]. The production of ROS is prevalent in the world’s oceans, and oxidative stress is an 
important component of the stress response in marine organisms. In marine systems, the absorption of 
solar radiation by dissolved organic matter in seawater leads to the photochemical production of 
diverse reactive transients, including ROS. Since marine organisms cannot avoid these challenges, they 
produce compounds that can operate as antioxidant defenses [35]. 
It is well known that the genus, Shewanella (Bacteria 16), produces long-chain polyunsaturated 
fatty acids, and recent studies associated these compounds with an efficient antioxidant system 
mechanism, which operates as a primary protective “breakwater” for all marine microorganisms 
possessing them [35]. This can explain the high antioxidant activity shown by Bacteria 16  
(Shewanella sp.). 
Besides the production of antioxidant compounds, marine bacteria also have the ability to produce 
antimicrobial compounds that play an important role in the protection against other pathogenic and 
fouling microorganisms [22]. 
In this work, the antimicrobial activity of compounds produced by B. bifurcata epiphytic  
bacteria was also evaluated against several microorganisms, including human pathogens, namely 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Saccharomyces 
cerevisiae, Salmonella enteritidis and Bacillus subtilis. Extracts were tested against all the mentioned 
microorganisms at 1 mg/mL; the ones that presented a capacity to inhibit the microorganism’s growth 
in more than 50% (IC50 < 1 mg/mL) were also evaluated through dose-response analysis (10, 30, 100, 
300 and 1000 µg/mL), and the IC50 was determined. The B. bifurcata-associated bacteria extracts did 
not show antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, Candida albicans, 
Saccharomyces cerevisiae and Salmonella enteritidis (data not shown). However, several of the  
B. bifurcata-associated bacteria extracts induced high antibacterial activity against Bacillus subtilis and 
Staphylococcus aureus (Table 3). The obtained IC50 ranged from 2.29 µg/mL (1.79–2.94) to  
621.4 µg/mL (508.2–759.9) exhibited by Bacteria 16 (Shewanella sp.) and 13 (Vibrio sp.), 
respectively, against B. subtilis, and 50.85 µg/mL (40.72–63.50) to 722.9 µg/mL (541.11–965.9) 
exhibited by Bacteria 34 (Alteromonas sp.) and 4 (Cellulophaga sp.), respectively, against S. aureus. 
Actually, the potency of some bacteria extracts against B. subtilis growth, such as Bacteria 16 
(Shewanella sp.), 25 (Shewanella sp.), 17 (Shewanella sp.), 34 (Alteromonas sp.) and 24, was even 
higher than that of the commercial antibiotic, chloramphenicol. Moreover, the B. bifurcata-associated 
bacteria extracts from the Bacteria 13B (Serratia sp.), 39 (Vibrio sp.), 50 (Vibrio sp.) and 38 had a 
chloramphenicol similar potency. 
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Table 3. Antibacterial activity of Bifurcaria bifurcata epiphytic bacteria. The results are 
the mean ± SEM of eight independent experiments. Bacitracin, chloramphenicol, 
oxytetracycline and ampicillin were used as positive controls. 
Epiphytic bacteria 
B. subtilis S. aureus 
IC50 (µg/mL) IC50 (µg/mL) 
2 95.06 (82.41–109.7) >1000 
3 122.4 (87.66–170.9) 95.54 (67.26–135.7) 
4 >1000 722.9 (541.11–965.9) 
6 102.5 (68.34–153.9) 63.48 (52.77–76.38) 
9 532.3 (452.2–626.6) >1000 
13 621.4 (508.2–759.9) >1000 
14 148.5 (115.9–190.4) >1000 
15 126.4 (91.68–174.2) >1000 
16 2.29 (1.79–2.94) >1000 
17 36.97 (29.97–45.60) >1000 
18 98.32 (84.47–114.4) >1000 
23 739 (525.5–1039) 136.6 (102.8–181.6) 
24 47.39 (30.12–74.58) >1000 
25 31.01 (21.49–44.75) >1000 
30 71.35 (54.19–93.94) >1000 
32 >1000 127.1 (85.79–188.4) 
34 24.17 (14.9–39.20) 50.85 (40.72–63.50) 
35 303.3 (144.5–636.5) >1000 
38 58.87 (41.39–83.74) >1000 
39 58.86 (43.60–79.46) >1000 
40 411.5 (323.8–522.9) >1000 
50 62.54 (39.57–98.86) >1000 
13 B 52.42 (37.00–74.27) >1000 
Bacitracin 4.09 (3.30–5.06) 4.05 (3.35–4.90) 
Chloramphenicol 48.14 (33.73–68.71) 26.01 (19.06–35.5) 
Oxytetracycline 0.16 (0.128–0.19) 0.40 (0.265–0.610) 
Ampicillin 0.16 (0.124–0.21) 0.04 (0.028–0.05) 
The extracts from Strains 34 and 6, which belong to the Alteromonas genus, showed the highest 
antimicrobial activity against Staphylococcus aureus with an IC50 of 50.85 and 43.48 µg/mL, 
respectively. In line with our results, Barja and co-workers [36] isolated antimicrobial compounds 
from Alteromonas sp. that exhibited a broad inhibition, including against Staphylococcus aureus. 
Furthermore, Shiozawa and co-workers isolated a new antibiotic also produced by Alteromonas sp. 
with high antibacterial activity [37]. In another study, Alteromonas sp. isolated from a marine 
invertebrate also exhibited high antimicrobial activity, namely against fish pathogenic bacteria [38]. 
It is widely accepted that marine organisms produce compounds to survive and adapt to the 
unfavorable conditions where in which they live, and the production of antimicrobial compounds by 
marine bacteria seems to be a powerful weapon in space competition, namely for surfaces 
colonization. Other strains of Bacillus are current in the marine environment. For instance, Bacillus 
licheniformis (strain EI-34-6) and Bacillus subtilis (strain II-111-5) were isolated from the marine alga, 
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Palmaria palmate [39]. Therefore, Bacillus strains are direct competitors of other species of marine 
epiphytic bacteria, like Shewanella sp., Alteromonas sp., Serratia sp. and Vibrio sp., which can explain 
the high antimicrobial activity of these bacteria’s extracts against Bacillus subtilis. In line with these 
findings, it was not surprising that more than 50% of the total bacteria isolated from the B. bifurcata 
macro-alga presented antibacterial activity against B. subtilis. 
According to the literature, the production of antimicrobial compounds by marine organisms against 
Gram-positive bacteria seems to be more frequent [1]. The generally low activity of compounds 
against Gram-negative organisms may be due to the fact that Gram-negative bacteria possess an outer 
membrane and a periplasmic space, both of which are absent in Gram-positive bacteria. The outer 
membrane of Gram-negative bacteria is known to present a barrier to the penetration of numerous 
antibiotic molecules. In addition, the periplasmic space contains enzymes that are capable of breaking 
down foreign molecules introduced from the outside [40]. Moreover, microbial competition for limited 
natural resources within a community is thought to be an important selective force that promotes the 
biosynthesis of antimicrobial compounds. From an ecological point of view, the inhibition of other 
marine bacterial species competing for the same niche will give a selective advantage during 
colonization [41]. In this study, the weak inhibitory effect against most bacteria and fungi can provide 
evidence of a lack of competition for the same niche. 
In this study, some bacterial extracts revealed positive bioactivity results, and given that these are 
multi-component extracts, there is a potential for discovering multiple active compounds in a single 
fraction, making these organisms a valuable source of novel substances for future marine drug 
discovery. The very high antioxidant and antimicrobial activities observed could be associated with 
low-abundant substances, indicating a high potency for these compounds, especially for Bacteria 16 
(Shewanella sp.), which revealed huge antioxidant and antimicrobial activities. 
3. Experimental Section 
3.1. Isolation and Purification of Epiphytic Marine Bacteria 
Marine alga Bifurcaria bifurcata was collected from the Peniche coast and transported in seawater 
to the lab. Portions of alga were rinsed thoroughly with sterile seawater to remove loosely attached 
bacteria and then swabbed with a sterile cotton-tipped swab. The swab was then used to directly 
inoculate plates with Marine-Agar (peptone, 5 g; yeast extract, 1 g; FePO4, 0.1 g; agar, 15 g; dissolved 
in 1 L of seawater; pH 7.2–7.6), which were incubated at 20 °C. Colonies were selected at random and 
by systematic sampling, with distinctive colony types being selected along with a random sample from 
each plate. For purifying bacteria, we performed the streak technique at least 5 times. 
3.2. Bacterial DNA Extraction and Identification 
DNA was extracted from previously stored bacterial pellets with the GeneJET™ Genomic DNA 
Purification Kit (Thermo Fisher Scientific, Vilnius, Lithuania), according to the manufacturer’s instructions. 
Genus-level identification of isolates was determined by 16S rRNA gene sequencing. 16S rRNA gene 
fragments of ca. 1500 bp in length were amplified using the bacterial universal primers, F27 (5′-AGA 
GTTTGATCMTGGCTCAG-3′) and R1492 (5′-TACGGYTACCTTGTTACGACTT-3′) [16]. Reaction 
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mixtures (25 mL) were prepared as follows: 8.75 µL of ultrapure water, 5 µL of GoTaq
®
 Flexi DNA 
Polymerase Buffer (Promega, Madison, WI, USA), 3 µL of MgCl2, 25 mM, 2.5 µL dNTPs, 2 mM,  
1.5 µL of each primer, 10 µM, 1.25 of dimethyl sulfoxide (DMSO) 100%, 0.5 µL GoTaq
®
 Flexi DNA 
Polymerase 5U/µL and 1 µL of DNA template. Thermal cycling started with an initial denaturation 
step of 94 °C for 3 min, 35 cycles of 94 °C for 1 min, 55 °C for 1 min, 72 °C for 72 min and a final 
extension step of 72 °C for 10 min. All PCR amplifications were carried out in a Gradient Thermal 
cycler (Thermo Fisher Scientific, Waltham, MA, USA). All amplicons were checked under UV light 
after electrophoresis in 1.5% agarose gels stained with RedSafe™ (iNtRON Biotechnology, 
Seongnam-Si, Korea). PCR products with the right size (ca. 1500 bp) were cleaned with DNA Clean & 
Concentrator™-5 (Zymo Research Europe GmbH, Freiburg, Deutschland) columns and subjected to 
sequencing with the Sanger method in a BigDye Terminator 3 (Applied Biosystems, Foster City, 
CA, USA) using the forward and reverse primer. Nearly complete 16S rRNA gene sequences were 
obtained by sequencing with the forward and reverse primers. All sequences were automatically 
trimmed using the Phred quality score method [42]. Their closest phylogenetic relatives were searched 
for using the Basic Local Alignment Search Tool (BLAST, National Library of Medicine, Bethesda, 
MD, USA) of the National Center for Biotechnology Information (NCBI, National Library of 
Medicine, Bethesda, MD, USA) database. 
3.3. Preparation of Epiphytic Bacteria Extracts 
Isolated bacteria were cultured in 500 mL of Marine Broth (peptone, 5 g; yeast extract, 1 g; FePO4,  
0.1 g; dissolved in 1 L seawater; pH 7.2–7.6) and incubated with aeration for three days at 25 °C. 
Bacteria cells were centrifuged and the pellet recovered and lyophilized. Lyophilized cells were then 
extracted with methanol and dichloromethane (1:1) at constant stirring for 12 h. The solvents were 
evaporated in a rotary evaporator at 40 °C, and the extracts were solubilized in dimethyl sulfoxide 
(DMSO) and stored at −20 °C until further use. 
3.4. Biological Activities 
3.4.1. Antioxidant Activities 
3.4.1.1. Quantification of Total Phenolic Content (TPC) 
The TPC of bacteria extracts was determined using the Folin-Ciocalteu method adapted to  
the microscale [43]. Briefly, 2 µL of sample were added to 158 µL of distilled water, 10 µL of  
Folin-Ciocalteu reagent and 30 µL of 20% sodium carbonate. After one hour of reaction in the dark, the 
absorbance was measured at 755 nm (Synergy H1 Multi-Mode Microplate Reader, BioTek
®
 
Instruments, Winooski, Vermont, USA) and used to calculate the phenolic content using gallic acid as 
the standard. 
3.4.1.2. DPPH Radical Scavenging Activity 
The DPPH free radical scavenging method was performed according to Brand-Williams (1995) [44] 
adapted to the microscale with slight modifications. The DPPH radical was dissolved in methanol  
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(0.1 mM). Various concentrations of 2 µL of sample solution were added to 198 µL of the DPPH 
radical solution. The mixture was vortexed for 1 min and allowed to stand at room temperature in the 
dark for 30 min, at which time, the decrease in absorbance at 517 nm was measured (Synergy H1 
Multi-Mode Microplate Reader, BioTek
®
 Instruments). The radical solution was freshly prepared each 
day. The synthetic antioxidant, BHT, was used as the standard. The ability to scavenge the DPPH 
radical was calculated using the follow equation: 
                      
    sample                
        
      (1) 
where Acontrol is the absorbance of the control (198 µL of DPPH solution plus 2 µL DMSO), Asample is 
the absorbance of the test sample (198 µL of DPPH solution plus 2 µL sample) and Asample blank is the 
absorbance of the sample in methanol (198 µL of MeOH plus 2 µL of sample). 
3.4.1.3. Oxygen Radical Absorbent Capacity (ORAC) 
The oxygen radical absorbance capacity assay (ORAC) method was performed as described by 
Dávalos and co-workers [45] as follows: the reaction was carried out in 75 mM phosphate buffer  
(pH 7.4), and the final reaction mixture was 200 µL. The sample (20 µL) and fluorescein (120 µL;  
70 nM, final concentration) were placed in the well of the microplate. The mixture was pre-incubated 
for 15 min at 37 °C. 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH), a free radical generator, 
was rapidly added using a multichannel pipet (60 µL; 12 mM, final concentration). The microplate was 
immediately placed in the reader and the fluorescence recorded every minute for 240 min.  
The microplate was automatically shaken prior to each reading. Trolox (6-hydroxy-2,5,7, 
8-tetramethylchroman-2-carboxylic acid), which is a hydrophilic analogue of vitamin E, was used to 
perform eight calibration solutions (1–8 µM, final concentration) on each assay together with a blank 
using phosphate buffer instead of the fluorescein. 
Antioxidant curves (fluorescence versus time) were first normalized to the curve of  
the blank corresponding to the same assay by multiplying original data by the factor 
fluorescenceblank,t=0/fluorescencesample,t=0. From the normalized curves, the area under the fluorescence 
decay curve (AUC) was calculated as: 
                     (2) 
where f0 is the initial fluorescence reading at 0 min and fi is the fluorescence reading at time i. The net 
AUC corresponding to a sample was calculated by subtracting the AUC corresponding to the blank. 
Regression equations between net AUC and antioxidant concentration were calculated for all the 
samples. ORAC values were expressed as micromoles of Trolox equivalent/gram of extract by using 
the standard curve calculated for each assay. 
3.4.2. Antimicrobial Activity 
The antimicrobial activity of bacteria extracts was evaluated against seven microorganisms: 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Bacillus subtilis (ATCC 
6633) and Salmonella enteritidis (ATCC 13076) cultured in Luria broth (LB); Staphylococcus aureus 
(ATCC 25923) cultured in trypticase soy yeast extract medium (TSYE); and Saccharomyces 
Mar. Drugs 2014, 12 1686 
 
 
cerevisiae (ATCC 9763) and Candida albicans (ATCC 10231) cultured in yeast extract peptone 
dextrose (YPD) medium. All mediums were obtained from Merck (Darmstadt, Germany). 
Microorganisms growth was monitored spectrophotometrically (optical density at 600 nm (OD600)) 
during 48 h (data not shown) to determine the beginning of the exponential phase, in which the effect 
of bacterial extracts compared with the vehicle (microorganisms growth in the presence of 1% DMSO) 
will be assessed. 
The antimicrobial assays were performed in 96-well plates, where 193 µL of medium,  
5 µL of microorganism inoculum and 2 µL of extracts samples were added per well. Bacteria were 
incubated at 37 °C and fungi at 30 °C. As positive controls, ampicillin (0.01–1 µg/mL), amphotericin b 
(1–100 µg/mL), bacitracin (0.1–10 µg/mL), chloramphenicol (1–100 µg/mL) and oxytetracycline 
(0.01–1 µg/mL), purchased from Sigma Aldrich (Oakville, Canada), were used, previously prepared in 
sterile-filtered DMSO and stored at −20 °C. The ability of bacteria extracts to inhibit the 
microorganisms growth was accompanied by optical density at 600 nm (Synergy H1 Multi-Mode 
Microplate Reader, BioTek
®
 Instruments). Results were expressed in the percentage of control. 
3.5. Statistical Analysis 
Results are presented as the mean ± standard error of mean (SEM). The IC50 concentration was 
calculated from nonlinear regression analysis using the GraphPad Prism software with the equation:  
Y = 100/(1 + 10
(X − LogIC50)). 
4. Conclusions 
To the best of our knowledge, for the first time, Bifurcaria bifurcata-associated bacteria were 
isolated and identified. This study reveals that B. bifurcata epiphytic bacteria are an excellent source of 
new natural antioxidant compounds, as well as antimicrobial compounds against Gram-positive 
bacteria. Moreover, all bacteria presented in this work are cultivable in a flask scale, which opens an 
opportunity for the production of the bioactive compounds in an industrial scale. As the production of 
secondary metabolites is related to environmental factors, such as UV radiation, pH, temperature, 
nutrient availability and time of fermentation, these can be manipulated in order to expose the bacteria 
to stress situations eliciting the production of the target bioactive compound. From a biotechnological 
perspective, the production of secondary metabolites, as effective competition and defense strategies 
by surface-associated microorganisms, constitutes an unparalleled reservoir for the discovery of new 
drugs, therapeutic agents and bioactive molecules, with applications across medical, industrial and 
environmental settings. 
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